Showalter, M. R., Hatakeyama, J., Cajka, T., VanderVorst, K., Carraway, K. L., & Fiehn, O. (2017). Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. eLife.
استشهاد بنمط شيكاغوShowalter, Megan Reed, Jason Hatakeyama, Tomas Cajka, Kacey VanderVorst, Kermit L. Carraway, و Oliver Fiehn. "Replication Study: The Common Feature of Leukemia-associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting Alpha-ketoglutarate to 2-hydroxyglutarate." ELife 2017.
MLA استشهادShowalter, Megan Reed, et al. "Replication Study: The Common Feature of Leukemia-associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting Alpha-ketoglutarate to 2-hydroxyglutarate." ELife 2017.